Pear Therapeutics, Inc. — Form D/A
Pear Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D amendment with the SEC on 2021-03-02. The offering totals $132.0M, of which $132.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2021-03-02
- Form: D/A
- Accession: 0001615898-21-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $132.0M
- Amount sold: $132.0M
- Investors: 22
- Date of first sale: 2020-12-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-383679
Issuer
- Name: Pear Therapeutics, Inc.
- CIK: 0001615898
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 200 STATE STREET, 13TH FLOOR, BOSTON, MA, 02109
- Phone: 6469322774
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Zack Lynch | Director | San Francisco, CA |
| Corey McCann | Director | Boston, MA |
| Timothy Petersen | Director | Waltham, MA |
| Nancy Schlichting | Director | Boston, MA |
| Andrew Schwab | Director | BOSTON, MA |
| Elena Viboch | Director | Menlo Park, CA |
| Christopher Guiffre | Executive Officer | Boston, MA |
| Yuri Maricich | Executive Officer | Boston, MA |
| Corey McCann | Executive Officer | Boston, MA |
| Ronan O'Brien | Executive Officer | Boston, MA |
| Julia Strandberg | Executive Officer | Boston, MA |
| Andrew J Schwab | Director | San Francisco, CA |
| Alex Waldron | Executive Officer | New Haven, CT |
| Jeremy Gilbert | Executive Officer | Boston, MA |
| Hongjie Hu | Director | Boston, MA |
| Antoun Nabhan | Executive Officer | Boston, MA |
| Tim J Petersen | Director | Boston, MA |
| Zack J Lynch | Director | Boston, MA |
Other filings by this issuer (4)
More